Piper Sandler Maintains Overweight on Organon, Raises Price Target to $24
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst David Amsellem has maintained an Overweight rating on Organon (NYSE:OGN) and increased the price target from $22 to $24.

April 29, 2024 | 11:44 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Piper Sandler maintains an Overweight rating on Organon and raises the price target from $22 to $24.
The increase in price target by a reputable analyst firm like Piper Sandler suggests a positive outlook on Organon's stock, likely due to anticipated performance improvements or market conditions favoring the company. This can lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100